— Know what they know.
Not Investment Advice

IDT.AX ASX

IDT Australia Limited
1W: -8.9% 1M: -10.9% 3M: +28.1% YTD: -8.9% 1Y: -36.9% 3Y: -28.7% 5Y: -92.9%
A$0.04 ($0.03)
-0.00 (-2.22%)
 
Weekly Expected Move ±9.2%
A$0 A$0 A$0 A$0 A$0
ASX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · A$17.5M mcap · 347M float · 0.062% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapA$17.5M ($12.2M)
52W Range0.03-0.07
Volume480,045
Avg Volume214,772
Beta0.93
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMark Simari
Employees156
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1988-04-01
45 Wadhurst Drive
Boronia, VIC 3155
AU
61 3 9801 8888
About IDT Australia Limited

IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications. Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms. Notably, IDT Australia also provides medicinal cannabis products and a broad array of contract manufacturing solutions. Established in 1975, the firm is headquartered in Boronia, Australia.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms